1. Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
- Author
-
Ribés-Cruz JJ, Torregrosa-Maicas I, Ramos-Tomás C, Solís-Salguero MA, Puchades-Montesa MJ, González-Rico MA, Juan-García I, Tomás-Simó P, Tejedor-Alonso S, Zambrano-Esteves P, and Miguel-Carrasco A
- Subjects
- Aged, 80 and over, Atrial Fibrillation complications, Benzimidazoles administration & dosage, Benzimidazoles pharmacokinetics, Benzimidazoles therapeutic use, Dabigatran, Diabetes Mellitus, Type 2 complications, Erythrocyte Transfusion, Female, Gastrointestinal Hemorrhage diagnosis, Gastrointestinal Hemorrhage therapy, Glomerular Filtration Rate, Humans, Hypertension complications, Metabolic Clearance Rate, Renal Dialysis, Renal Insufficiency, Chronic metabolism, Renal Insufficiency, Chronic therapy, Thrombophilia etiology, Urinary Tract Infections complications, beta-Alanine administration & dosage, beta-Alanine adverse effects, beta-Alanine pharmacokinetics, beta-Alanine therapeutic use, Benzimidazoles adverse effects, Gastrointestinal Hemorrhage chemically induced, Renal Insufficiency, Chronic complications, Thrombophilia drug therapy, beta-Alanine analogs & derivatives
- Published
- 2013
- Full Text
- View/download PDF